Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study. Arch Ital Urol Androl [Internet]. 2026 Aug. 7 [cited 2026 Aug. 12];. Available from: https://www.pagepressjournals.org/aiua/article/view/15630